Inspection Record

Richmond VA Medical Center — FDA 483 Findings

US FDAInspected 2026-05-12Published 2026-07-06 8 findingsTraining and personnelAseptic processing and sterility assuranceEquipment and facilityOther quality system

Inspectors Tekalign Wondimu · Michael O IdowuThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Training and personnel

Personnel were observed moving quickly in a critical area or in an area immediately adjacent to a critical area likely causing disruption of unidirectional airflow.

2Aseptic processing and sterility assurance

Personnel performed aseptic manipulations with exposed hair or skin.

3Equipment and facility

Lack of disinfection of equipment at each transition from areas of lower quality air to areas of higher quality air.

4Equipment and facility

Failure to appropriately and regularly clean and disinfect or sterilize equipment located in the ISO 5 area.

5Aseptic processing and sterility assurance

Smoke studies were not performed under dynamic conditions.

6Aseptic processing and sterility assurance

Personnel were observed conducting aseptic manipulations where the movement of "first air" in the ISO 5 area is blocked or disrupted.

7Equipment and facility

Use of a sporicidal agent in the facility's ISO 5 areas was improper.

8Other quality system

Use of a disinfectant in a manner insufficient to achieve adequate levels of disinfection.

About this record

Extracted automatically from the document US FDA published on 2026-07-06. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Richmond VA Medical Center company profile — full history US FDA documents, 2026 Go to Findings search